Sanofi stops all but the most urgent trips to China; Flurry of orphan drug designations arrive
→ Over at Novartis execs rolled their Q4 numbers out with calming words about any effect the Wuhan virus outbreak could be having on operations. There have been no interruptions in the supply chain, they say. But at Sanofi, things are somewhat different. The Paris-based giant put out a statement today saying that any trips to China are being cancelled unless it’s an absolute emergency. They also noted:
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.